<DOC>
	<DOC>NCT01246791</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetic profiles of norethisterone and ethinyl estradiol after single oral administration of NPC-01 in healthy female volunteers. Pharmacokinetics of norethisterone and ethinyl estradiol will be evaluated on the basis of AUC, Cmax, tmax, t1/2, MRT, kel and AUCâˆž.</brief_summary>
	<brief_title>Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Mestranol</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Norinyl</mesh_term>
	<criteria>Healthy female aged between 20 to 35 years BMI:18.026.0 Females who are pregnant Drug use affecting sex hormone secretion</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>NPC-01</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy female volunteer</keyword>
	<keyword>Norethisterone</keyword>
	<keyword>Ethinyl Estradiol</keyword>
</DOC>